Viking's VK2735 shows promise in obesity treatment but faces tolerability concerns. Discover market impact, buyout potential, and investment insights.
Viking: Still On Track, But The Compass Needs Recalibration (NASDAQ:VKTX)

24
Viking's VK2735 shows promise in obesity treatment but faces tolerability concerns. Discover market impact, buyout potential, and investment insights.